The observed reduction of TNF-α, IL-6 and IL-1β achieved by using CGS 21680 or Cl-IB-MECA corroborated the anti-inflammatory effects of A2A and A3AR activation and their potential therapeutic role, at least in RA. The gene discussed is IL1B; the disease is rheumatoid arthritis.